{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T06:58:01Z","timestamp":1782197881491,"version":"3.54.5"},"reference-count":123,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,15]],"date-time":"2017-09-15T00:00:00Z","timestamp":1505433600000},"content-version":"am","delay-in-days":349,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["320030_130243"],"award-info":[{"award-number":["320030_130243"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["310030_166202"],"award-info":[{"award-number":["310030_166202"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Foundation","doi-asserted-by":"publisher","award":["32003B-127613"],"award-info":[{"award-number":["32003B-127613"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Foundation","doi-asserted-by":"publisher","award":["324730-144054"],"award-info":[{"award-number":["324730-144054"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006387","name":"Leenaards Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006387","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007667","name":"Santos-Suarez Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007667","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001774","name":"Sydney Medical Foundation, University of Sydney","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council of Australia","doi-asserted-by":"publisher","award":["1053206"],"award-info":[{"award-number":["1053206"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council of Australia","doi-asserted-by":"publisher","award":["APP1107178"],"award-info":[{"award-number":["APP1107178"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council of Australia","doi-asserted-by":"publisher","award":["APP1108422"],"award-info":[{"award-number":["APP1108422"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.jhep.2016.07.037","type":"journal-article","created":{"date-parts":[[2016,9,16]],"date-time":"2016-09-16T05:05:46Z","timestamp":1474002346000},"page":"S22-S32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"special_numbering":"S","title":["Host \u2013 hepatitis C viral interactions: The role of genetics"],"prefix":"10.1016","volume":"65","author":[{"given":"Markus H.","family":"Heim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Yves","family":"Bochud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2016.07.037_b0005","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S1473-3099(05)70216-4","article-title":"Global epidemiology of hepatitis C virus infection","volume":"5","author":"Shepard","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jhep.2016.07.037_b0010","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.jhep.2008.07.005","article-title":"Acute hepatitis C: current status and remaining challenges","volume":"49","author":"Santantonio","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.07.037_b0015","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJM200107053450107","article-title":"Hepatitis C virus infection","volume":"345","author":"Lauer","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2016.07.037_b0020","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1053\/jhep.2001.27831","article-title":"Estimating progression to cirrhosis in chronic hepatitis C virus infection","volume":"34","author":"Freeman","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.07.037_b0025","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/hep.22375","article-title":"Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: a meta-analysis and meta-regression","volume":"48","author":"Thein","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.07.037_b0030","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/j.gastro.2011.12.061","article-title":"Epidemiology of viral hepatitis and hepatocellular carcinoma","volume":"142","author":"El-Serag","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2016.07.037_b0035","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nature08463","article-title":"Genetic variation in IL28B and spontaneous clearance of hepatitis C virus","volume":"461","author":"Thomas","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2016.07.037_b0040","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1053\/j.gastro.2009.12.056","article-title":"Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study","volume":"138","author":"Rauch","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2016.07.037_b0045","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/ng.449","article-title":"Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C","volume":"41","author":"Tanaka","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2016.07.037_b0050","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/ng.447","article-title":"IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy","volume":"41","author":"Suppiah","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2016.07.037_b0055","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/ng.2521","article-title":"A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus","volume":"45","author":"Prokunina-Olsson","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2016.07.037_b0060","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1084\/jem.20130012","article-title":"IL28B expression depends on a novel TT\/-G polymorphism which improves HCV clearance prediction","volume":"210","author":"Bibert","year":"2013","journal-title":"J Exp Med"},{"key":"10.1016\/j.jhep.2016.07.037_b0065","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/ni.3212","article-title":"Guarding the frontiers: the biology of type III interferons","volume":"16","author":"Wack","year":"2015","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jhep.2016.07.037_b0070","doi-asserted-by":"crossref","first-page":"7059","DOI":"10.1128\/JVI.75.15.7059-7066.2001","article-title":"DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection","volume":"75","author":"Bigger","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2016.07.037_b0075","doi-asserted-by":"crossref","first-page":"15661","DOI":"10.1073\/pnas.202608299","article-title":"Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease","volume":"99","author":"Thimme","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2016.07.037_b0080","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1002\/hep.20239","article-title":"Hepatitis C virus kinetics and host responses associated with disease and outcome of infection in chimpanzees","volume":"39","author":"Major","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.07.037_b0085","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1053\/j.gastro.2005.01.049","article-title":"Mathematical modeling of primary hepatitis C infection: noncytolytic clearance and early blockage of virion production","volume":"128","author":"Dahari","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2016.07.037_b0090","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.jhep.2014.06.035","article-title":"Innate and adaptive immune responses in HCV infections","volume":"61","author":"Heim","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.07.037_b0095","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1053\/j.gastro.2012.05.044","article-title":"Interferon-gamma-Stimulated Genes, but Not USP18, are expressed in livers of patients with acute hepatitis C","volume":"143","author":"Dill","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2016.07.037_b0100","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1038\/emboj.2013.232","article-title":"Interferon lambda 4 signals via the IFNlambda receptor to regulate antiviral activity against HCV and coronaviruses","volume":"32","author":"Hamming","year":"2013","journal-title":"EMBO J"},{"key":"10.1016\/j.jhep.2016.07.037_b0105","doi-asserted-by":"crossref","first-page":"5699","DOI":"10.1038\/ncomms6699","article-title":"Reduced IFNlambda4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes","volume":"5","author":"Terczynska-Dyla","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2016.07.037_b0110","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1189\/jlb.0812395","article-title":"Interferon-lambda (IFN-lambda) induces signal transduction and gene expression in human hepatocytes, but not in lymphocytes or monocytes","volume":"93","author":"Dickensheets","year":"2013","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jhep.2016.07.037_b0115","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1084\/jem.20140995","article-title":"IFN-lambda resolves inflammation via suppression of neutrophil infiltration and IL-1beta production","volume":"212","author":"Blazek","year":"2015","journal-title":"J Exp Med"},{"key":"10.1016\/j.jhep.2016.07.037_b0120","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.jhep.2012.10.005","article-title":"Innate immunity and HCV","volume":"58","author":"Heim","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.07.037_b0125","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1002\/hep.23912","article-title":"IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C","volume":"52","author":"Urban","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.07.037_b0130","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1053\/j.gastro.2010.04.049","article-title":"Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C","volume":"139","author":"Honda","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2016.07.037_b0135","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1053\/j.gastro.2010.11.039","article-title":"Interferon-induced gene expression is a stronger predictor of treatment response than IL28B genotype in patients with hepatitis C","volume":"140","author":"Dill","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2016.07.037_b0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084026","article-title":"Interferon-lambda4 (IFNL4) Transcript Expression in Human Liver Tissue Samples","volume":"8","author":"Amanzada","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2016.07.037_b0145","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1084\/jem.20131557","article-title":"IFN-lambda receptor 1 expression is induced in chronic hepatitis C and correlates with the IFN-lambda3 genotype and with nonresponsiveness to IFN-alpha therapies","volume":"211","author":"Duong","year":"2014","journal-title":"J Exp Med"},{"key":"10.1016\/j.jhep.2016.07.037_b0150","doi-asserted-by":"crossref","first-page":"7034","DOI":"10.1073\/pnas.0707882105","article-title":"Interferon signaling and treatment outcome in chronic hepatitis C","volume":"105","author":"Sarasin-Filipowicz","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2016.07.037_b0155","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1002\/hep.24189","article-title":"Interferon-beta and interferon-lambda signaling is not affected by interferon-induced refractoriness to interferon-alpha in vivo","volume":"53","author":"Makowska","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.07.037_b0160","doi-asserted-by":"crossref","first-page":"4841","DOI":"10.1128\/MCB.00224-09","article-title":"Alpha interferon induces long-lasting refractoriness of JAK-STAT signaling in the mouse liver through induction of USP18\/UBP43","volume":"29","author":"Sarasin-Filipowicz","year":"2009","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jhep.2016.07.037_b0165","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nri3463","article-title":"25 years of interferon-based treatment of chronic hepatitis C: an epoch coming to an end","volume":"13","author":"Heim","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jhep.2016.07.037_b0170","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1002\/hep.26770","article-title":"Simultaneous detection of hepatitis C virus and interferon stimulated gene expression in infected human liver","volume":"59","author":"Wieland","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.07.037_b0175","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1126\/science.1178178","article-title":"Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection","volume":"327","author":"Lanford","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.jhep.2016.07.037_b0180","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1053\/j.gastro.2005.01.059","article-title":"Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection","volume":"128","author":"Chen","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2016.07.037_b0185","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1136\/gut.2007.128611","article-title":"Liver gene expression signature to predict response to pegylated interferon plus ribavirin combination therapy in patients with chronic hepatitis C","volume":"57","author":"Asselah","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2016.07.037_b0190","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1136\/gutjnl-2011-300620","article-title":"T cell responses in hepatitis C: the good, the bad and the unconventional","volume":"61","author":"Klenerman","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2016.07.037_b0195","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1172\/JCI39133","article-title":"Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence","volume":"119","author":"Rehermann","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2016.07.037_b0200","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.jhep.2014.05.043","article-title":"Restoration of HCV-specific CD8+ T cell function by interferon-free therapy","volume":"61","author":"Martin","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.07.037_b0205","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/jvh.12465","article-title":"Memory re-differentiation and reduced lymphocyte activation in chronic HCV-infected patients receiving direct-acting antivirals","volume":"22","author":"Burchill","year":"2015","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhep.2016.07.037_b0210","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1002\/hep.23515","article-title":"Specific human leukocyte antigen class I and II alleles associated with hepatitis C virus viremia","volume":"51","author":"Kuniholm","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.07.037_b0215","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.3748\/wjg.v13.i12.1770","article-title":"A comparative review of HLA associations with hepatitis B and C viral infections across global populations","volume":"13","author":"Singh","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2016.07.037_b0220","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/jmv.24334","article-title":"Host genetic variants influencing the clinical course of hepatitis C virus infection","volume":"88","author":"Matsuura","year":"2016","journal-title":"J Med Virol"},{"key":"10.1016\/j.jhep.2016.07.037_b0225","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1046\/j.1365-2893.2000.00022.x","article-title":"D. Immunogenetics of hepatitis C virus","volume":"7","author":"McKiernan","year":"2000","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhep.2016.07.037_b0230","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S0198-8859(99)00021-X","article-title":"Study of the association between major histocompatibility complex class II genes and the response to interferon alpha in patients with chronic hepatitis C infection","volume":"60","author":"Alric","year":"1999","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jhep.2016.07.037_b0235","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1053\/gast.1997.v113.pm9352872","article-title":"Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection","volume":"113","author":"Alric","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2016.07.037_b0240","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1034\/j.1399-0039.2000.560207.x","article-title":"Study of host- and virus-related factors associated with spontaneous hepatitis C virus clearance","volume":"56","author":"Alric","year":"2000","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.jhep.2016.07.037_b0245","doi-asserted-by":"crossref","first-page":"235","DOI":"10.7326\/0003-4819-158-4-201302190-00003","article-title":"Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts","volume":"158","author":"Duggal","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhep.2016.07.037_b0250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084226","article-title":"HLA-DQB1\u221703 confers susceptibility to chronic hepatitis C in Japanese: a genome-wide association study","volume":"8","author":"Miki","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2016.07.037_b0255","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.3389\/fmicb.2015.01061","article-title":"NK cell function and receptor diversity in the context of HCV infection","volume":"6","author":"Gardiner","year":"2015","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jhep.2016.07.037_b0260","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1126\/science.1097670","article-title":"HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection","volume":"305","author":"Khakoo","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.jhep.2016.07.037_b0265","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1002\/hep.23477","article-title":"Consistent beneficial effects of killer cell immunoglobulin-like receptor 2DL3 and group 1 human leukocyte antigen-C following exposure to hepatitis C virus","volume":"51","author":"Knapp","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.07.037_b0270","doi-asserted-by":"crossref","first-page":"5736","DOI":"10.1073\/pnas.1016358108","article-title":"Innate immune genes synergize to predict increased risk of chronic disease in hepatitis C virus infection","volume":"108","author":"Dring","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2016.07.037_b0275","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1399-0039.2006.773_4.x","article-title":"Influence of inhibitory killer immunoglobulin-like receptors and their HLA-C ligands on resolving hepatitis C virus infection","volume":"69","author":"Rauch","year":"2007","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.jhep.2016.07.037_b0280","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.humimm.2006.02.001","article-title":"HLA-C and KIR genes in hepatitis C virus infection","volume":"66","author":"Montes-Cano","year":"2005","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jhep.2016.07.037_b0285","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jhep.2014.04.020","article-title":"KIR2DL3(+)NKG2A(-) natural killer cells are associated with protection from productive hepatitis C virus infection in people who inject drugs","volume":"61","author":"Thoens","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.07.037_b0290","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0066831","article-title":"Variation in both IL28B and KIR2DS3 genes influence pegylated interferon and ribavirin hepatitis C treatment outcome in HIV-1 co-infection","volume":"8","author":"Keane","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2016.07.037_b0295","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00535-005-1558-3","article-title":"SNPs in the promoter region of the osteopontin gene as a marker predicting the efficacy of interferon-based therapies in patients with chronic hepatitis C","volume":"40","author":"Naito","year":"2005","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.jhep.2016.07.037_b0300","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.6061\/clinics\/2013(10)06","article-title":"Myxovirus resistance, osteopontin and suppressor of cytokine signaling 3 polymorphisms predict hepatitis C virus therapy response in an admixed patient population: comparison with IL28B","volume":"68","author":"Angelo","year":"2013","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/j.jhep.2016.07.037_b0305","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/cbf.2954","article-title":"Osteopontin gene polymorphisms as predictors for the efficacy of interferon therapy in chronic hepatitis C Egyptian patients with genotype 4","volume":"31","author":"Shaker","year":"2013","journal-title":"Cell Biochem Funct"},{"key":"10.1016\/j.jhep.2016.07.037_b0310","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1159\/000050075","article-title":"Genetic polymorphism of the MxA gene promoter and interferon responsiveness of hepatitis C patients: revisited by analyzing two SNP sites (-123 and -88) in vivo and in vitro","volume":"44","author":"Hijikata","year":"2001","journal-title":"Intervirology"},{"key":"10.1016\/j.jhep.2016.07.037_b0315","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nature08825","article-title":"ITPA gene variants protect against anaemia in patients treated for chronic hepatitis C","volume":"464","author":"Fellay","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2016.07.037_b0320","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1093\/hmg\/ddr249","article-title":"Genome-wide association study identified ITPA\/DDRGK1 variants reflecting thrombocytopenia in pegylated interferon and ribavirin therapy for chronic hepatitis C","volume":"20","author":"Tanaka","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jhep.2016.07.037_b0325","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jhep.2011.04.021","article-title":"Genome-wide association study of interferon-related cytopenia in chronic hepatitis C patients","volume":"56","author":"Thompson","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.07.037_b0330","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1056\/NEJMoa1213557","article-title":"Faldaprevir and deleobuvir for HCV genotype 1 infection","volume":"369","author":"Zeuzem","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2016.07.037_b0335","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1002\/hep.26641","article-title":"Once-daily simeprevir (TMC435) with pegylated interferon and ribavirin in treatment-naive genotype 1 hepatitis C: the randomized PILLAR study","volume":"58","author":"Fried","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.07.037_b0340","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1056\/NEJMoa1214853","article-title":"Sofosbuvir for previously untreated chronic hepatitis C infection","volume":"368","author":"Lawitz","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2016.07.037_b0345","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/hep.28467","article-title":"Simeprevir plus sofosbuvir (12 and 8 weeks) in hepatitis C virus genotype 1-infected patients without cirrhosis: OPTIMIST-1, a phase 3, randomized study","volume":"64","author":"Kwo","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.07.037_b0350","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1093\/infdis\/jit827","article-title":"IFNL4-DeltaG genotype is associated with slower viral clearance in hepatitis C, genotype-1 patients treated with sofosbuvir and ribavirin","volume":"209","author":"Meissner","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jhep.2016.07.037_b0355","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1053\/j.gastro.2011.12.057","article-title":"Effect of IL28B genotype on early viral kinetics during interferon-free treatment of patients with chronic hepatitis C","volume":"142","author":"Chu","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2016.07.037_b0360","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/hep.28255","article-title":"Interferon lambda 4 genotypes and resistance-associated variants in patients infected with hepatitis C virus genotypes 1 and 3","volume":"63","author":"Peiffer","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.07.037_b0365","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1128\/JVI.01993-15","article-title":"Distinct escape pathway by hepatitis C virus genotype 1a from a dominant CD8+ T cell response by selection of altered epitope processing","volume":"90","author":"Walker","year":"2016","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2016.07.037_b0370","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1084\/jem.20041006","article-title":"CD8 epitope escape and reversion in acute HCV infection","volume":"200","author":"Timm","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.jhep.2016.07.037_b0375","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1053\/j.gastro.2011.02.060","article-title":"CD8+ T-cell response promotes evolution of hepatitis C virus nonstructural proteins","volume":"140","author":"Ruhl","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2016.07.037_b0380","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1136\/gut.52.4.574","article-title":"Measurement and determinants of the natural history of liver fibrosis in hepatitis C virus infection: a cross sectional and longitudinal study","volume":"52","author":"Wright","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2016.07.037_b0385","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1136\/gut.2010.228262","article-title":"Insulin resistance and hepatitis C: an evolving story","volume":"60","author":"Eslam","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2016.07.037_b0390","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1053\/j.gastro.2015.08.011","article-title":"Heritability of hepatic fibrosis and steatosis based on a prospective twin study","volume":"149","author":"Loomba","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2016.07.037_b0395","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/hep.24678","article-title":"IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypes","volume":"55","author":"Bochud","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.07.037_b0400","doi-asserted-by":"crossref","first-page":"6422","DOI":"10.1038\/ncomms7422","article-title":"Interferon-lambda rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease","volume":"6","author":"Eslam","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2016.07.037_b0405","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029370","article-title":"Impact of IL28B-related single nucleotide polymorphisms on liver histopathology in chronic hepatitis C genotype 2 and 3","volume":"7","author":"Rembeck","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2016.07.037_b0410","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1365-2893.2011.01481.x","article-title":"Role of hepatitis C virus genotype 3 in liver fibrosis progression\u2013a systematic review and meta-analysis","volume":"18","author":"Probst","year":"2011","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhep.2016.07.037_b0415","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1001\/jama.2012.144878","article-title":"Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis","volume":"308","author":"van der Meer","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.jhep.2016.07.037_b0420","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/hep.26639","article-title":"The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection","volume":"59","author":"Grebely","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.07.037_b0425","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017232","article-title":"Response prediction in chronic hepatitis C by assessment of IP-10 and IL28B-related single nucleotide polymorphisms","volume":"6","author":"Lagging","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2016.07.037_b0430","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1002\/hep.26506","article-title":"Association of IL28B genotype with fibrosis progression and clinical outcomes in patients with chronic hepatitis C: a longitudinal analysis","volume":"58","author":"Noureddin","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.07.037_b0435","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.antiviral.2014.11.002","article-title":"Interferon lambda-3 is not associated with clinical outcome in patients with HCV-induced compensated cirrhosis: a long-term cohort study","volume":"113","author":"Bruno","year":"2015","journal-title":"Antiviral Res"},{"key":"10.1016\/j.jhep.2016.07.037_b0440","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.jhep.2010.07.019","article-title":"IL-28B rs12979860 C\/T allele distribution in patients with liver cirrhosis: role in the course of chronic viral hepatitis and the development of HCC","volume":"54","author":"Fabris","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.07.037_b0445","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1007\/s00535-013-0826-x","article-title":"IL28B minor allele is associated with a younger age of onset of hepatocellular carcinoma in patients with chronic hepatitis C virus infection","volume":"49","author":"Sato","year":"2014","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.jhep.2016.07.037_b0450","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.cgh.2014.10.035","article-title":"A polymorphism in interferon L3 is an independent risk factor for development of hepatocellular carcinoma after treatment of hepatitis C virus infection","volume":"13","author":"Chang","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2016.07.037_b0455","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/TP.0b013e318244f774","article-title":"Role of IL28B polymorphism in the development of hepatitis C virus-induced hepatocellular carcinoma, graft fibrosis, and posttransplant antiviral therapy","volume":"93","author":"Eurich","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2016.07.037_b0460","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1055\/s-0035-1567830","article-title":"Genome-Wide Association Studies and Hepatitis C: Harvesting the Benefits of the Genomic Revolution","volume":"35","author":"Eslam","year":"2015","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2016.07.037_b0465","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1053\/j.gastro.2012.07.097","article-title":"Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infection","volume":"143","author":"Patin","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2016.07.037_b0470","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.jhep.2012.12.024","article-title":"A genome-wide association study of HCV-induced liver cirrhosis in the Japanese population identifies novel susceptibility loci at the MHC region","volume":"58","author":"Urabe","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.07.037_b0475","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/ng.809","article-title":"Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinoma","volume":"43","author":"Kumar","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2016.07.037_b0480","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/ng.876","article-title":"Variation in the DEPDC5 locus is associated with progression to hepatocellular carcinoma in chronic hepatitis C virus carriers","volume":"43","author":"Miki","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2016.07.037_b0485","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ng.257","article-title":"Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease","volume":"40","author":"Romeo","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2016.07.037_b0490","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1002\/hep.23622","article-title":"Homozygosity for the patatin-like phospholipase-3\/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease","volume":"51","author":"Valenti","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.07.037_b0495","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jhep.2014.02.030","article-title":"Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma","volume":"61","author":"Liu","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.07.037_b0500","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/hep.24350","article-title":"Impact of patatin-like phospholipase-3 (rs738409 C>G) polymorphism on fibrosis progression and steatosis in chronic hepatitis C","volume":"54","author":"Trepo","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.07.037_b0505","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/hep.28475","article-title":"Diverse impacts of the rs58542926 E167K variant in TM6SF2 on viral and metabolic liver disease phenotypes","volume":"64","author":"Eslam","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.07.037_b0510","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/ng.2901","article-title":"Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease","volume":"46","author":"Kozlitina","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2016.07.037_b0515","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1038\/ncomms5309","article-title":"TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease","volume":"5","author":"Liu","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2016.07.037_b0520","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/hep.27811","article-title":"Transmembrane 6 superfamily member 2 gene E167K variant impacts on steatosis and liver damage in chronic hepatitis C patients","volume":"62","author":"Milano","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.07.037_b0525","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1093\/nar\/gkn1004","article-title":"Cellular versus viral microRNAs in host-virus interaction","volume":"37","author":"Ghosh","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jhep.2016.07.037_b0530","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jhep.2014.10.004","article-title":"MiR-122\u2013a key factor and therapeutic target in liver disease","volume":"62","author":"Bandiera","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.07.037_b0535","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.jhep.2008.01.019","article-title":"MiR-122, a paradigm for the role of microRNAs in the liver","volume":"48","author":"Girard","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.07.037_b0540","doi-asserted-by":"crossref","first-page":"6615","DOI":"10.1128\/JVI.00417-10","article-title":"Regulation of hepatitis C virus translation and infectious virus production by the microRNA miR-122","volume":"84","author":"Jangra","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2016.07.037_b0545","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1038\/emboj.2008.244","article-title":"MicroRNA-122 stimulates translation of hepatitis C virus RNA","volume":"27","author":"Henke","year":"2008","journal-title":"EMBO J"},{"key":"10.1016\/j.jhep.2016.07.037_b0550","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMoa1209026","article-title":"Treatment of HCV infection by targeting microRNA","volume":"368","author":"Janssen","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2016.07.037_b0555","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/nature08494","article-title":"Finding the missing heritability of complex diseases","volume":"461","author":"Manolio","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2016.07.037_b0560","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000337","article-title":"Interpretation of genetic association studies: markers with replicated highly significant odds ratios may be poor classifiers","volume":"5","author":"Jakobsdottir","year":"2009","journal-title":"PLoS Genet."},{"key":"10.1016\/j.jhep.2016.07.037_b0565","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nrg3523","article-title":"Bringing genome-wide association findings into clinical use","volume":"14","author":"Manolio","year":"2013","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.jhep.2016.07.037_b0570","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1136\/gutjnl-2014-306997","article-title":"Impact of common risk factors of fibrosis progression in chronic hepatitis C","volume":"64","author":"Rueger","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2016.07.037_b0575","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/nrg3118","article-title":"Rare and common variants: twenty arguments","volume":"13","author":"Gibson","year":"2011","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.jhep.2016.07.037_b0580","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jhep.2016.03.011","article-title":"PNPLA3 gene in liver diseases","volume":"65","author":"Trepo","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.07.037_b0585","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/bmb\/lds009","article-title":"The genetics of coronary heart disease","volume":"102","author":"Swerdlow","year":"2012","journal-title":"Br Med Bull"},{"key":"10.1016\/j.jhep.2016.07.037_b0590","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/hep.21695","article-title":"A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C","volume":"46","author":"Huang","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.07.037_b0595","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jhep.2015.11.008","article-title":"FibroGENE: A gene-based model for staging liver fibrosis","volume":"64","author":"Eslam","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.07.037_b0600","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1002\/hep.27131","article-title":"Epigenetics in liver disease","volume":"60","author":"Mann","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.07.037_b0605","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1016\/S0140-6736(14)60269-5","article-title":"Epigenetics in health and disease: heralding the EWAS era","volume":"383","author":"Murphy","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2016.07.037_b0610","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/ng1089","article-title":"Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals","volume":"33","author":"Jaenisch","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2016.07.037_b0615","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/nature05329","article-title":"Global variation in copy number in the human genome","volume":"444","author":"Redon","year":"2006","journal-title":"Nature"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827816304111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827816304111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T11:28:57Z","timestamp":1718796537000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827816304111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":123,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S0168827816304111"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2016.07.037","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Host \u2013 hepatitis C viral interactions: The role of genetics","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2016.07.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}